Andover, Mass.-based biopharmaceutical company Pfizer began constructing its new $200 million biologics manufacturing facility Thursday.
The five-story, 175,000-square-foot addition to Pfizer's Andover campus is slated for completion in January 2019. The endeavor will create 75 new permanent jobs for Pfizer and 200 temporary construction jobs. Five separate manufacturing suites will be built.
"The expansion of Pfizer's presence in Andover will provide state-of-the-art manufacturing to help bring new medicines and vaccines to the patients we serve," said John Ludwig, senior vice president of BioTherapeutics Pharmaceutical Sciences in Pfizer R&D. "Andover is a crucial part of our global footprint for both clinical and commercial manufacturing, and we believe it provides an attractive location for growth in the coming years."
Pfizer currently employs approximately 2,000 in Massachusetts.